Life
Study Uncovers Genetic Factors Impacting Ozempic's Effectiveness
A recent study suggests that around 10% of individuals may not experience the full benefits of diabetes and weight-loss medications like Ozempic and Wegovy due to specific genetic variants.
editorial-staff
1 min read
Updated 1 day ago
Summary
A new study has highlighted that popular medications such as Ozempic and Wegovy may not be effective for everyone. Approximately 10% of users could be affected by this issue.
The research points to genetic variants that impact the efficacy of these drugs, particularly in relation to GLP-1 receptor activity.
This finding raises important considerations for both patients and healthcare providers regarding personalized treatment approaches.
Updates
- No subsequent updates recorded.